A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers
Introduction: Over 50% of patients with colorectal cancer (CRC) will progress and/or develop metastases. Biomarkers capable of predicting progression, risk stratification and therapeutic benefit are needed. Cancer stem cells are thought to be responsible for tumor initiation, dissemination and treat...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Ivyspring International Publisher
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366478/ |